Wound Healing, Burns, Wounds and Injuries
Conditions
Interventions
This is a randomized, double-blind, controlled clinical trial with parallel groups. The sample will consist of 39 subjects with second-degree burns, aged over 18 years, of both sexes, with stable phys
infrared LED group (13 subjects), which will receive infrared LED phototherapy
and placebo group (13 subjects), who will be submitted to a simulated application of LED therapy at the burn site. Volunteers will not know which group they will be allocated to. All participants will
E02.774
Sponsors
Universidade Federal da Paraíba
Universidade Federal da Paraíba
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Volunteers who have suffered second degree burns; over 18 years of age; of both sexes; with stable physical state; no pre-existing metabolic diseases; able to carry out physical therapy treatment; in good mental health; without the presence of infection in the injured tissues; without the use of medications that alter the healing process.
Exclusion criteria
Exclusion criteria: Volunteers who develop associated dermatological diseases or infectious processes will be excluded from the study, as well as those who do not complete the therapeutic or evaluation procedure and those who drop out of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Re-epithelialization rate, measured in number of days between the start of treatment and the total healing process, and by measuring the wound area in cm2 using Image J ® software version 1.36 b. | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin temperature (oC) of the burned area, captured using the FlirOne camera (FLIR Systems, Inc., Wilsonville, OR), and analyzed using the FLIR tools software (in terms of mean and standard deviation of the temperature of the burned area).;Pain intensity in the treated area, measured using the Visual Analog Scale (VAS) on a scale from 0 to 10.;Scar mobility, measured after complete healing of the burn, using the Adheremeter instrument, compared to the healthy contralateral side.;Scar quality, assessed by the Vancouver scale, whose score ranges from 0 (normal) to 13 (poor).;Pruritus, measured using the scale for intensity of pruritus, ranging from 0 (no pruritus) to 21 points (most severe pruritus), with a clinically important difference of two points. | — |
Countries
Brazil
Contacts
Public ContactPalloma Andrade
Outcome results
None listed